To enumerate 8–16V/HLA and 7–16V/HLA complexes expressed by KRASG12V cancer cell lines, we performed targeted mass spectrometry and absolute peptide quantitation on HLA-A*03:01– or HLA-A*11:01–engineered CORL23, SW620, and YAPC tumor cells. This evidence concerns the gene HLA-A and cancer.